Wednesday, February 10, 2010, 1:53am EST - Canadian Markets open in 7 hours and 37 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Haemonetics Corp. (HAE)

 On Feb 9: 52.79 USD  Down 0.47 (0.88%)  
MORE ON HAE
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HAEMONETICS CP (NYSE:HAE) Delayed quote dataEdit
After Hours: 52.79 0.00 (0.00%) as of 4:34pm EST on 02/09/10
Last Trade: 52.79 USD
Trade Time: Feb 9
Change: Down 0.47 (0.88%)
Prev Close: 53.26
Open: 53.70
Bid: N/A
Ask: N/A
1y Target Est: 66.20
Day's Range: 52.66 - 53.70
52wk Range: 46.78 - 63.75
Volume: 292,735
Avg Vol (3m): 186,356
Market Cap: 1.35B
P/E (ttm): 20.87
EPS (ttm): 2.53
Div & Yield: N/A (N/A%)
Haemonetics Corp. (HAE)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add HAE to Portfolio   Download Data

HEADLINES
• HAEMONETICS CORP Financials
EDGAR Online Financials (Tue 1:04pm)
• Award Winning Equity Analyst Sees 2010 Increase In Mergers And Acquisitions In Life Science Tools And Diagnostics Sector
Wall Street Transcript (Wed, Feb 3)
• Haemonetics Misses Zacks Estimate
Zacks.com (Tue, Feb 2)
• New Star Analyst Rankings for HAEMONETICS CP
StarMine (Tue, Feb 2)
• [$$] Pericom, PetroQuest, Kulicke & Soffa Jump
at The Wall Street Journal Online (Mon, Feb 1)
• Medical Devices Stock Review - Feb. 2010
Zacks.com (Mon, Feb 1)
• Haemonetics to buy Global Med Technologies in $60M deal
at bizjournals.com (Mon, Feb 1)
• Haemonetics shares dip on 3Q results; big purchase
AP (Mon, Feb 1)
• UPDATE - Haemonetics results misses view; to buy Global Med
at Reuters (Mon, Feb 1)
• HAEMONETICS CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Mon, Feb 1)
• Haemonetics Announces Definitive Agreement to Acquire Global Med Technologies, Inc.
PRNewswire (Mon, Feb 1)
• Haemonetics Reports Double Digit Growth in Earnings Per Share for Third Quarter Fiscal 2010
PRNewswire (Mon, Feb 1)
More Headlines for HAE...
ANALYST
EPS Est (next year) (Mar-10) : 2.83
EPS Est (in 2 years) (Mar-11) : 3.19
Avg Rec (current)*: 1.4
PEG Ratio: 1.24
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Haemonetics Corporation provides blood management solutions primarily in the United States, Europe, and Asia. The company’s donor products and services include plasma systems that automate the collection of plasma from donors; blood bank syst...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices